Table 1.
Description of the itraconazole formulations acquired as oral capsules according to the manufacturers
IDa | Origin | Use | Concentrationc | Origin of the pharmaceutical company |
---|---|---|---|---|
H-INDb | Brand name | Human | 10 mg/mL | Beerse, Belgium |
V-IND | Brand name | Veterinary | 2.5 mg/mL | São Paulo, SP, Brazil |
H-COMP1 | Compounded | Human | 6.4 mg/mL | Pelotas, RS, Brazil |
H-COMP2 | Compounded | Human | 6.5 mg/mL | Pelotas, RS, Brazil |
V-COMP | Compounded | Veterinary | 6.4 mg/mL | Pelotas, RS, Brazil |
aID identification
bReference drug
cConcentration after dissolution, according to the M38-A2 guidelines [12]